IE
TIL icon

Israel Englander’s Instil Bio TIL Stock Holding History

Israel Englander’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,885
Closed -$24.7K – 6529
2023
Q3 		$24.7K Buy
+2,885
New +$29.1K ﹤0.01% 5604

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Israel Englander's TIL Position: Q2 2026 in Review

Israel Englander increased its Instil Bio (TIL) stake by 1.2% in Q2 2026, buying an estimated $13.1K and bringing the position to 134,575 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #4290.

Israel Englander first reported a position in TIL in Q1 2021 and has held it in 15 quarters since. The position peaked at $8.72M in Q1 2021. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Israel Englander held 134,575 shares of Instil Bio worth $1.03M as of Q2 2026.
  • Israel Englander bought 1,629 Instil Bio shares in Q2 2026, an estimated $13.1K.
  • Instil Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4290 holding.
  • Israel Englander first reported a position in Instil Bio in Q1 2021 and has held it in 15 quarters since.
  • Israel Englander's Instil Bio position peaked at $8.72M in Q1 2021.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.